Skip to main content

Table 1 Summary of stakeholder involvement

From: Development of a core outcome set for clinical trials in basal cell carcinoma: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey

Key stakeholders
Physicians (including dermatologists, international providers, physicians of other health care fields)
Drug and device safety regulators (e.g., FDA, EMA)
Industry scientists
Nurses, physician assistants, or other health care providers
  1. EMA European Medicines Agency, FDA US Food and Drugs Administration